Cipla P/B Ratio
CIPLA • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
3.76
High Valuation
High - Premium to book value, growth expectations or asset-light model
Current Valuation Metrics
P/B Ratio
3.76
Current Price
₹1465.70
Book Value/Share
₹1931.42
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹31,289 Cr
Share Capital
₹162 Cr
Reserves & Surplus
₹31,032 Cr
Outstanding Shares
162,000,000
Book Value per Share
₹1931.42
Valuation Signal
Signal
Overvalued
Historical Avg
0.84
Historical Range
0.78 - 0.92
Percentile
100.0%
Sector Context
Sector Average
-0.1
Sector Median
0.66
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Cipla
- Stock appears overvalued with PB of 3.76, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 348.7% above historical average
- Trading at premium to sector average PB of -0.1
View the current stock price of Cipla for more insights.
P/B Ratio Historical Trend for Cipla
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Cipla
Additional stock information and data for CIPLA
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.78 | ₹1931.42 | ₹1511.30 | ₹31,289 | Low |
| 2024 | 0.92 | ₹1654.44 | ₹1529.00 | ₹26,802 | Low |
| 2023 | 0.85 | ₹1472.92 | ₹1246.30 | ₹23,714 | Low |
| 2022 | 0.82 | ₹1311.61 | ₹1075.95 | ₹21,117 | Low |
| 2021 | 0.82 | ₹1154.41 | ₹944.10 | ₹18,586 | Low |
Sector P/B Ratio Comparison
Comparing Cipla with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.97 | ₹4,391 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.26 | ₹55 | Low |